Clinical Trial Update: Platine, Avastin and OLAparib in 1st Line [Phase 3]

View source ↗

Summary

Phase 3 trial update involving Platine, Avastin, and OLAparib in first-line ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Olaparib (Olaparib)
• Platine (undefined)

Snippet

Sponsor: Arcagy Research | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED